Form 10-Q/A - Quarterly report [Sections 13 or 15(d)]: [Amend]
SEC Accession No. 0001731122-25-000250
Filing Date
2025-02-19
Accepted
2025-02-19 08:50:47
Documents
79
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q/A2 e6367_10qa2.htm   iXBRL 10-Q/A 1524454
2 EXHIBIT 31.1 e6367_ex31-1.htm EX-31.1 8266
3 EXHIBIT 31.2 e6367_ex31-2.htm EX-31.2 8207
4 EXHIBIT 32.1 e6367_ex32-1.htm EX-32.1 4579
5 EXHIBIT 32.2 e6367_ex32-2.htm EX-32.2 4668
  Complete submission text file 0001731122-25-000250.txt   8115791

Data Files

Seq Description Document Type Size
6 XBRL SCHEMA FILE renb-20240331.xsd EX-101.SCH 72807
7 XBRL CALCULATION FILE renb-20240331_cal.xml EX-101.CAL 54486
8 XBRL DEFINITION FILE renb-20240331_def.xml EX-101.DEF 288834
9 XBRL LABEL FILE renb-20240331_lab.xml EX-101.LAB 495341
10 XBRL PRESENTATION FILE renb-20240331_pre.xml EX-101.PRE 436269
81 EXTRACTED XBRL INSTANCE DOCUMENT e6367_10qa2_htm.xml XML 1207441
Mailing Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067
Business Address CENTURY CITY MEDICAL PLAZA 2080 CENTURY CITY EAST SUITE 906 LOS ANGELES CA 90067 45 39179840
RENOVARO INC. (Filer) CIK: 0001527728 (see all company filings)

EIN.: 452259340 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-Q/A | Act: 34 | File No.: 001-38758 | Film No.: 25637578
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)